We are excited to announce that John Driscoll has joined the Infinitus board of directors. Senior advisor at Walgreens Boots Alliance (WBA) and EQT Group, Driscoll brings with him more than 25 years of healthcare leadership experience.

Before joining WBA, Driscoll served as CEO at CareCentrix; as president at Castlight Health, a healthcare technology company; and as group president for new markets at Medco. He also founded and chaired the Surescripts ePrescribing Network. He currently chairs the board of the Waystar Corporation as well as Magnit and is on the board of Johns Hopkins Medicine. His experience and insight will be invaluable to the Infinitus team.

Driscoll recently took time out of his busy schedule to answer a few questions:

How did you first hear about Infinitus? 

I learned about Infinitus initially through my friends at Andreesen Horowitz. I was immediately intrigued, as I have struggled with the challenges of working with and managing call centers at nearly all of the health plans, pharmacy benefit managers (PBMs), and health tech companies that I have helped lead. 

What makes Infinitus stand apart from other healthcare technologies?

What I think helps Infinitus stand out is that the company is working on a huge practical problem where applied AI and advanced compute can make a high-impact contribution. 

Infinitus has the right talent, product, and product/market strategy at a time when everyone in healthcare is trying to figure out how AI-related solutions can help them solve the problems they face in their everyday workflow. 

Why do you think the work Infinitus is doing is relevant now?

Healthcare in the US costs too much and delivers too little. As our population continues to age, cost and performance will only grow as critical challenges. Infinitus’s products and tech can help simplify, automate, and improve workflow and help free us time and resources so that clinicians can invest more time with patients and caregivers – lowering the total cost of care and hopefully meaningfully improving it in the process. 

What do you think CEOs of leading healthcare companies need to know about Infinitus?

They need to know that the future is now in terms of automated solutions that make sense for their call centers. They need to understand how Infinitus can help them accelerate their innovation roadmaps by partnering with us to deliver next-level AI solutions.

Our company values help guide the actions we take in support of each other and our customers. Which of the “C.O.D.E.S” resonates most with you and why?

I like them all but what resonates for me is the optimistic realist – although I guess I am something of an optimistic paranoid myself! 

But back to the question: The future will be owned by the optimists. I have worked with breakthrough companies from managed care/Oxford, consumer internet/Priceline, eprescribing/Surescripts … all of whom were monster growth stories and great successes, and all of which were constructively improbable at the onset. You cannot see the future but you can imagine it. And you cannot create the future unless you are a realist. 

What excites you most about Infinitus and our future potential?

I think Infinitus has the right solutions at the right time. The market is ripe for improvement and disruption. Infinitus has a tech edge and the talent to win. There is a massive market to serve. And most of all, I really enjoy and admire our leadership team and board.

Learn more about John and his decision to join the Infinitus board in our press release.